89bio Inc (ETNB)
8.42
+0.16
(+1.94%)
USD |
NASDAQ |
Apr 29, 15:02
89bio Shares Outstanding: 95.22M for April 4, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
April 04, 2024 | 95.22M |
April 01, 2024 | 95.22M |
February 21, 2024 | 93.50M |
December 31, 2023 | 93.27M |
December 11, 2023 | 93.21M |
November 06, 2023 | 75.64M |
September 30, 2023 | 75.64M |
July 31, 2023 | 75.48M |
June 30, 2023 | 75.47M |
May 02, 2023 | 72.87M |
April 06, 2023 | 72.87M |
April 01, 2023 | 72.82M |
March 31, 2023 | 72.87M |
March 29, 2023 | 70.06M |
March 28, 2023 | 69.15M |
March 03, 2023 | 52.23M |
December 31, 2022 | 50.56M |
November 07, 2022 | 46.54M |
October 19, 2022 | 46.48M |
September 30, 2022 | 43.62M |
August 05, 2022 | 39.07M |
July 01, 2022 | 39.03M |
June 30, 2022 | 20.37M |
May 02, 2022 | 20.35M |
April 07, 2022 | 20.35M |
Date | Value |
---|---|
April 01, 2022 | 20.35M |
March 31, 2022 | 20.35M |
March 01, 2022 | 20.35M |
December 31, 2021 | 20.32M |
November 08, 2021 | 20.28M |
September 30, 2021 | 20.10M |
August 06, 2021 | 20.09M |
June 30, 2021 | 20.08M |
May 07, 2021 | 20.06M |
April 08, 2021 | 20.03M |
April 01, 2021 | 20.03M |
March 31, 2021 | 20.03M |
March 01, 2021 | 19.95M |
December 31, 2020 | 19.93M |
November 06, 2020 | 19.88M |
September 30, 2020 | 19.88M |
September 23, 2020 | 20.37M |
September 21, 2020 | 19.88M |
August 31, 2020 | 16.85M |
August 06, 2020 | 16.85M |
July 10, 2020 | 16.85M |
June 30, 2020 | 13.81M |
May 04, 2020 | 13.79M |
April 30, 2020 | 13.79M |
April 01, 2020 | 13.79M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
12.06M
Minimum
Oct 28 2019
95.22M
Maximum
Apr 01 2024
37.18M
Average
20.33M
Median
Shares Outstanding Benchmarks
Madrigal Pharmaceuticals Inc | 19.90M |
Akero Therapeutics Inc | 68.95M |
Viking Therapeutics Inc | 110.27M |
Galectin Therapeutics Inc | 61.90M |
Terns Pharmaceuticals Inc | 64.65M |